The Mayan Doomsday’s effect on survival outcomes in clinical trials - 11/01/13
Doi : 10.1503/cmaj.121616
Paul Wheatley-Price, MBChB MD ⁎
, Brian Hutton, MSc PhD, Mark Clemons, MBBS MD
, Brian Hutton, MSc PhD, Mark Clemons, MBBS MD Paul Wheatley-Price and Mark Clemons are from the Department of Medicine, Division of Medical Oncology. Brian Hutton is with the Ottawa Health Research Institute Methods Centre, University of Ottawa, Ottawa, Ont.
* Correspondence to: Paul Wheatley-Price
Esquema
© 2012
Canadian Medical Association. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 184 - N° 18
P. 2021-2022 - décembre 2012 Regresar al número¿Ya suscrito a @@106933@@ revista ?


